Table 1.
Subject | Diagnosis | Age, years | Sex | Hemolysis, mg/dl | Heme, μM | IL6, pg/ml | TNF, pg/ml |
---|---|---|---|---|---|---|---|
A | Knee injury | 38 | M | >1000 | 542 | 40,251 | 19.2 |
B | Knee injury | 15 | M | 50 | 56.7 | 43,150 | 31.6 |
C | Knee injury | 23 | F | <20 | 29.8 | 4621 | 8.7 |
D | Knee injury | 23 | M | <20 | 26.3 | 1344 | 7.4 |
E | Knee injury | 49 | M | <20 | 65.7 | 414 | 5.2 |
F | Knee injury | 18 | M | 20 | 91.7 | 386 | 4.1 |
G | Knee injury | 17 | F | >1000 | 221 | 438 | 6.6 |
H | Reference | 24 | M | <20 | Nd | 2.7 | 1.6 |
I | Reference | 17 | F | <20 | Nd | 28.2 | 4.8 |
Interleukin (IL) −6 and tumor necrosis factor (TNF) were assessed using Meso Scale discovery (MSD) immunoassay. M = male, F = female, Nd = not determined, Reference = knee-healthy subjects.